Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides supply chain design, planning, inventory optimization, transportation and logistics management, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, master data management, and other procurement and supply chain advisory services; and sales and commercial services in the lead-to-quote, quote-to-order, and customer service areas. In addition, the company offers IT services, which include end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. It serves banking, capital market, insurance, consumer goods, retail, life science, healthcare, high tech, and manufacturing and service industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.
IPO Year: 2007
Exchange: NYSE
Website: genpact.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/7/2025 | $45.00 → $60.00 | Hold → Buy | TD Cowen |
| 1/21/2025 | $44.00 → $55.00 | Hold → Buy | Jefferies |
| 7/17/2024 | $43.00 → $40.00 | Underweight → Neutral | JP Morgan |
| 1/30/2024 | $40.00 | Neutral | Mizuho |
| 12/15/2023 | $38.00 | Outperform → Neutral | Robert W. Baird |
| 8/22/2023 | $40.00 | Neutral → Underweight | JP Morgan |
| 7/18/2023 | $46.00 → $42.00 | Buy → Neutral | Citigroup |
| 12/15/2022 | $55.00 → $50.00 | Overweight → Neutral | JP Morgan |
| 2/14/2022 | $57.00 → $51.00 | Outperform → Market Perform | Cowen & Co. |
| 1/26/2022 | $54.00 | Hold | Jefferies |
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
8-K - Genpact LTD (0001398659) (Filer)
10-Q - Genpact LTD (0001398659) (Filer)
8-K - Genpact LTD (0001398659) (Filer)
DEFA14A - Genpact LTD (0001398659) (Filer)
DEFA14A - Genpact LTD (0001398659) (Filer)
DEF 14A - Genpact LTD (0001398659) (Filer)
10-K - Genpact LTD (0001398659) (Filer)
SCHEDULE 13G - Genpact LTD (0001398659) (Subject)
SCHEDULE 13G - Genpact LTD (0001398659) (Subject)
SCHEDULE 13G/A - Genpact LTD (0001398659) (Subject)
TD Cowen upgraded Genpact from Hold to Buy and set a new price target of $60.00 from $45.00 previously
Jefferies upgraded Genpact from Hold to Buy and set a new price target of $55.00 from $44.00 previously
JP Morgan upgraded Genpact from Underweight to Neutral and set a new price target of $40.00 from $43.00 previously
Mizuho initiated coverage of Genpact with a rating of Neutral and set a new price target of $40.00
Robert W. Baird downgraded Genpact from Outperform to Neutral and set a new price target of $38.00
JP Morgan downgraded Genpact from Neutral to Underweight and set a new price target of $40.00
Citigroup downgraded Genpact from Buy to Neutral and set a new price target of $42.00 from $46.00 previously
JP Morgan downgraded Genpact from Overweight to Neutral and set a new price target of $50.00 from $55.00 previously
Cowen & Co. downgraded Genpact from Outperform to Market Perform and set a new price target of $51.00 from $57.00 previously
Jefferies initiated coverage of Genpact with a rating of Hold and set a new price target of $54.00
AI-powered fulfillment solution accelerates property claims settlement time from weeks to days, enhancing customer experience NEW YORK, June 17, 2025 /PRNewswire/ -- Genpact (NYSE:G), a global advanced technology services and solutions company, today announced the launch of Genpact RapidReplace to transform personal property contents claims processing. This generative AI-powered solution streamlines the fulfillment process to enable straight-through processing (STP) and rapid goods replacement through Amazon Business for a better customer experience. "When individuals lose bel
Findings reveal significant AI adoption in insurance, but governance, change management, and lack of AI fluency limit growth and improved customer experiences NEW YORK, June 10, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, in collaboration with Amazon Web Services (AWS), today released a new report, Harness the winds of change: How to scale AI and build trust in insurance. With 69% of insurance companies having deployed AI but only 36% of US customers seeing an improved digital experience, the report underscores how the insurance industry still needs to scale AI to meet evolving customer expectations and accelerate growth. It also provides a s
NEW YORK, June 6, 2025 /PRNewswire/ -- Genpact Limited (NYSE:G), a global advanced technology services and solutions company, today announced that its board of directors has declared a cash dividend of $0.17 per common share for the second quarter of 2025. The dividend is payable on June 30, 2025 to shareholders of record as of the close of business on June 18, 2025. The declaration of any future dividends will be at the discretion of the board of directors. About Genpact Genpact (NYSE:G) is an advanced technology services and solutions company that delivers lasting value for
Combination will fast-track Genpact's expansion of advanced technology solutions, amplifying data and AI capabilities, domain expertise, and strategic partnerships NEW YORK, June 5, 2025 /PRNewswire/ -- Genpact (NYSE:G), a global advanced technology services and solutions company, today announced it has acquired XponentL Data, a data products and artificial intelligence (AI) solutions provider. XponentL brings differentiated domain-led data strategy, design, and engineering capabilities; deep industry experience; and strategic partnerships. This acquisition builds on Genpact's pivot to data, AI, and other advanced technologies, further enhancing Genpact's ability to help clients across the
NEW YORK, May 12, 2025 /PRNewswire/ -- Genpact (NYSE:G), an advanced technology services and solutions company, today announced it has been recognized as a Leader in the 2025 ISG Provider Lens™ for ServiceNow Ecosystem Partners in the United States. The ISG report highlights Genpact's innovative approach to deploying ServiceNow solutions to transform business operations, enhance efficiency, and drive enterprise-wide value. To download the full report, click here. "The ISG Provider Lens report recognizes Genpact's innovative use of AI-powered ServiceNow solutions to drive busin
Net Revenues of $1.215 billion, Up 7.4% (8.3% constant currency)1Data-Tech-AI Net Revenues of $582 million, Up 11.1% (11.7% constant currency)1Digital Operations Net Revenues of $633 million, Up 4.2% (5.4% constant currency)1Diluted EPS of $0.73, Up 14%; Adjusted Diluted EPS2 of $0.84, Up 16% NEW YORK, May 7, 2025 /PRNewswire/ -- Genpact Limited (NYSE:G), a global advanced technology services and solutions company, today announced financial results for the first quarter ended March 31, 2025. "We entered 2025 with strong momentum. Revenue in the first quarter grew 8% year-over-
VANCOUVER, BC, May 1, 2025 /PRNewswire/ - Augusta Gold Corp. (TSX:G; OTCQB: AUGG; FSE:11B), (TSX: G; OTCQB:AUGG; FSE:11B), FSE:11B) ("Augusta Gold" or the "Company") announces that it has extended the maturity date of its loan (the "Loan") with Augusta Investments Inc. (the "Lender") to November 30, 2025 (the "Extension") and borrowed an additional US$500,000 from the Lender under the terms of the Loan. About Augusta Gold Augusta Gold is an exploration and development company focused on building a long-term business that delivers stakeholder value through developing the Reward
Findings highlight strategies to drive AI adoption and reshape customer perceptions in insurance NEW YORK, April 29, 2025 /PRNewswire/ -- Genpact (NYSE:G), a global advanced technology services and solutions company, today announced new research uncovering uncertainty around AI adoption within the insurance industry – offering insurers insights to help turn customer skepticism into confidence and preference. New Genpact study reveals strategies to drive AI adoption and reshape customer perceptions in insuranceThe study reveals that a majority (55%) of US adult respondents feel
Recognized for advanced technology leadership in driving innovation and efficiency across the P&C value chain NEW YORK, April 22, 2025 /PRNewswire/ -- Genpact (NYSE:G), a global advanced technology services and solutions company, today announced that it is recognized as a Leader in NelsonHall's 2025 NEAT evaluation for P&C Operations: Analytics & AI. This recognition highlights Genpact's leadership in delivering AI- and analytics-driven innovation that enhances underwriting, claims management, and customer service for property and casualty (P&C) insurers. To download the repor
NEW YORK, April 10, 2025 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the first quarter ended March 31, 2025, after the close of the U.S. financial markets on Wednesday, May 7, 2025. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live webcast will be availab
4 - Genpact LTD (0001398659) (Issuer)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)